The	O
myeloid	B-DNA
zinc	I-DNA
finger	I-DNA
gene	I-DNA
,	O
MZF-1	B-DNA
,	O
regulates	O
the	O
CD34	B-DNA
promoter	I-DNA
in	O
vitro	O
.	O

MZF-1	B-DNA
is	O
a	O
C2H2	B-DNA
zinc	I-DNA
finger	I-DNA
gene	I-DNA
encoding	O
a	O
putative	B-protein
transcriptional	I-protein
regulator	I-protein
of	O
myeloid	O
differentiation	O
.	O

The	O
MZF-1	B-DNA
protein	O
contains	O
13	O
C2H2	B-protein
zinc	I-protein
fingers	I-protein
arranged	O
in	O
bipartite	O
DNA	B-protein
binding	I-protein
domains	I-protein
containing	O
zinc	B-protein
fingers	I-protein
through	O
4	O
and	O
,	O
in	O
the	O
carboxy-terminus	B-protein
,	O
5	O
through	O
13	O
.	O

We	O
previously	O
identified	O
the	O
DNA	B-DNA
consensus	I-DNA
binding	I-DNA
site	I-DNA
recognized	O
by	O
the	O
two	O
DNA	B-protein
binding	I-protein
domains	I-protein
.	O

To	O
assess	O
the	O
transcription	O
regulatory	O
function	O
of	O
MZF-1	B-DNA
,	O
the	O
full-length	O
MZF-1	B-DNA
coding	O
region	O
was	O
fused	O
to	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
of	O
the	O
yeast	B-protein
transactivator	I-protein
GAL4	I-protein
.	O

The	O
expression	O
vector	O
was	O
cotransfected	O
with	O
the	O
chloramphenicol	B-DNA
acetyl	I-DNA
transferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
reporter	I-DNA
gene	I-DNA
regulated	O
by	O
the	O
thymidine	B-DNA
kinase	I-DNA
promoter	I-DNA
containing	O
GAL4	B-DNA
DNA	I-DNA
binding	I-DNA
sites	I-DNA
into	O
NIH	B-cell_line
3T3	I-cell_line
,	O
293	B-cell_line
,	O
K562	B-cell_line
,	O
and	O
Jurkat	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

MZF-1	B-DNA
represses	O
CAT	B-DNA
reporter	I-DNA
gene	I-DNA
expression	O
via	O
GAL4	B-protein
binding	O
sites	O
in	O
the	O
nonhematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
NIH	B-cell_line
3T3	I-cell_line
and	O
293	B-cell_line
.	O

In	O
contrast	O
,	O
MZF-1	B-DNA
activates	O
CAT	B-DNA
reporter	I-DNA
gene	I-DNA
expression	O
in	O
the	O
hematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
K562	B-cell_line
and	O
Jurkat	B-cell_line
.	O

The	O
MZF-1	B-DNA
binding	I-DNA
sites	I-DNA
are	O
present	O
in	O
the	O
promoters	B-DNA
of	O
several	O
genes	B-DNA
expressed	O
during	O
myeloid	O
differentiation	O
,	O
including	O
the	O
CD34	B-DNA
promoter	I-DNA
.	O

MZF-1	B-DNA
transcriptional	O
regulation	O
of	O
this	O
physiologically	B-DNA
relevant	I-DNA
promoter	I-DNA
was	O
assessed	O
in	O
both	O
hematopoietic	B-cell_line
and	O
nonhematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Recombinant	B-protein
MZF-1	I-protein
protein	I-protein
specifically	O
binds	O
to	O
the	O
consensus	B-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
CD34	B-DNA
promoter	I-DNA
in	O
mobility	O
shift	O
assays	O
.	O

MZF-1	B-DNA
expression	O
vectors	O
were	O
cotransfected	O
with	O
the	O
luciferase	B-DNA
reporter	I-DNA
plasmids	I-DNA
regulated	O
by	O
the	O
CD34	B-DNA
promoter	I-DNA
into	O
both	O
nonhematopoietic	B-cell_line
and	I-cell_line
hematopoietic	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

As	O
with	O
the	O
heterologous	O
DNA	B-protein
binding	I-protein
domain	I-protein
,	O
MZF-1	B-DNA
represses	O
reporter	B-DNA
gene	I-DNA
expression	O
in	O
nonhematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
and	O
activates	O
expression	O
in	O
hematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Activation	O
of	O
CD34	B-protein
expression	O
in	O
hematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
is	O
dependent	O
on	O
the	O
presence	O
of	O
intact	O
MZF-1	B-DNA
binding	I-DNA
sites	I-DNA
.	O

The	O
cell	O
type-specific	O
regulation	O
of	O
the	O
CD34	B-DNA
promoter	I-DNA
by	O
MZF-1	B-DNA
suggests	O
the	O
presence	O
of	O
tissue-specific	O
regulators/adapters	O
or	O
differential	O
MZF-1	B-DNA
modifications	O
that	O
determine	O
MZF-1	B-DNA
transcriptional	O
regulatory	O
function	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
The	NULL
Myeloid	NULL
Zinc	NULL
Finger	NULL
Gene	NULL
,	NULL
MZF-1	NULL
,	NULL
Regulates	NULL
the	NULL
CD34	NULL
Promoter	NULL
In	NULL
Vitro	NULL
By	NULL
Jennifer	NULL
F.	NULL
Morris	NULL
,	NULL
Frank	NULL
J.	NULL
Rauscher	NULL
III	NULL
,	NULL
Brian	NULL
Davis	NULL
,	NULL
Michael	NULL
Klemsz	NULL
,	NULL
Dawei	NULL
Xu	NULL
,	NULL
Daniel	NULL
Tenen	NULL
,	NULL
and	NULL
Robert	NULL
Hromas	NULL
MZF-1	NULL
is	NULL
a	NULL
C2H2	NULL
zinc	NULL
finger	NULL
gene	NULL
encoding	NULL
a	NULL
putative	NULL
transcriptional	NULL
regulator	NULL
of	NULL
myeloid	NULL
differentiation	NULL
.	NULL

The	NULL
MZF-1	NULL
protein	NULL
contains	NULL
13	NULL
C2H2	NULL
zinc	NULL
fingers	NULL
arranged	NULL
in	NULL
bipartite	NULL
DNA	NULL
binding	NULL
domains	NULL
containing	NULL
zinc	NULL
fingers	NULL
1	NULL
through	NULL
4	NULL
and	NULL
,	NULL
in	NULL
the	NULL
carboxy-terminus	NULL
,	NULL
5	NULL
through	NULL
13	NULL
.	NULL

We	NULL
previously	NULL
identified	NULL
the	NULL
DNA	NULL
consensus	NULL
binding	NULL
site	NULL
recognized	NULL
by	NULL
the	NULL
two	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
transcription	NULL
regulatory	NULL
function	NULL
of	NULL
MZF-1	NULL
,	NULL
the	NULL
full-length	NULL
MZF-1	NULL
coding	NULL
region	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
transacti-vator	NULL
GAL4	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
regulated	NULL
by	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
containing	NULL
GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
into	NULL
NIH	NULL
313	NULL
,	NULL
293	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
.	NULL

MZF-1	NULL
represses	NULL
CAT	NULL
reporter	NULL
gene	NULL
expression	NULL
via	NULL
GAL4	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
NIH	NULL
3T3	NULL
and	NULL
293	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
MZF-1	NULL
activates	NULL
CAT	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
K562	NULL
and	NULL
Jurkat	NULL
.	NULL

The	NULL
MZF-1	NULL
binding	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
expressed	NULL
during	NULL
myeloid	NULL
differentiation	NULL
,	NULL
in	NULL
EMATOPOIESIS	NULL
is	NULL
a	NULL
complex	NULL
process	NULL
during	NULL
which	NULL
pluripotent	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
proliferate	NULL
,	NULL
differentiate	NULL
,	NULL
and	NULL
mature	NULL
into	NULL
individual	NULL
peripheral	NULL
blood	NULL
cell	NULL
types	NULL
.	NULL

At	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
the	NULL
process	NULL
of	NULL
hematopoiesis	NULL
is	NULL
best	NULL
described	NULL
as	NULL
a	NULL
tightly	NULL
regulated	NULL
signal	NULL
transduction	NULL
cascade	NULL
.	NULL

Environmental	NULL
signals	NULL
are	NULL
received	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
by	NULL
growth	NULL
factors	NULL
binding	NULL
to	NULL
receptors	NULL
.	NULL

This	NULL
initial	NULL
signal	NULL
is	NULL
transduced	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
via	NULL
secondary	NULL
mes-sengers	NULL
,	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
specific	NULL
transcription	NULL
factors	NULL
From	NULL
Pediatric	NULL
Hematology/Oncology	NULL
,	NULL
Medical	NULL
College	NULL
of	NULL
Wis-consin	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
;	NULL
The	NULL
Wistar	NULL
Institute	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
;	NULL
The	NULL
Cancer	NULL
Center	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Texas	NULL
Medical	NULL
Branch	NULL
at	NULL
Galveston	NULL
,	NULL
Galveston	NULL
,	NULL
TX	NULL
;	NULL
Hematology/Oncology	NULL
and	NULL
Microbiclogy/Immu-nology	NULL
,	NULL
The	NULL
Walther	NULL
Oncology	NULL
Center	NULL
,	NULL
The	NULL
Indiana	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Submitted	NULL
June	NULL
30	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
August	NULL
23	NULL
,	NULL
1995	NULL
.	NULL

RH	NULL
.	NULL

is	NULL
a	NULL
scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
Grant	NULL
No	NULL
.	NULL

HL	NULL
48914	NULL
.	NULL

FJ.R	NULL
.	NULL

is	NULL
a	NULL
Pew	NULL
Scholar	NULL
of	NULL
the	NULL
Biomedical	NULL
Sciences	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
Grants	NULL
No	NULL
.	NULL

CA52009	NULL
and	NULL
CA47983	NULL
and	NULL
Core	NULL
Grant	NULL
No	NULL
.	NULL

CA10815	NULL
from	NULL
the	NULL
NIH	NULL
.	NULL

FJ.R	NULL
.	NULL

is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
W.W.	NULL
Smith	NULL
Charitable	NULL
Trust	NULL
,	NULL
the	NULL
Irving	NULL
A.	NULL
Hansen	NULL
Memorial	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Mary	NULL
A.H.	NULL
Rumsey	NULL
Foundation	NULL
.	NULL

J.M	NULL
.	NULL

is	NULL
a	NULL
Cancer	NULL
Research	NULL
Institute	NULL
fellow	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
NIH	NULL
Grant	NULL
No	NULL
.	NULL

CA69141	NULL
and	NULL
the	NULL
Zink	NULL
the	NULL
Zebra	NULL
Foundation	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Robert	NULL
Hromas	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Hematology/Oncology	NULL
,	NULL
Indiana	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
975	NULL
W	NULL
Walnut	NULL
St	NULL
,	NULL
Library	NULL
Bldg	NULL
442	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
46202-5121	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8610-0049	NULL
$	NULL
3.00/0	NULL
3640	NULL
cluding	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

MZF-1	NULL
transcriptional	NULL
regulation	NULL
of	NULL
this	NULL
physiologically	NULL
relevant	NULL
promoter	NULL
was	NULL
assessed	NULL
in	NULL
both	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

Recombinant	NULL
MZEF-1	NULL
protein	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

MZF-1	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
regulated	NULL
by	NULL
the	NULL
CD34	NULL
promoter	NULL
into	NULL
both	NULL
nonhematopoietic	NULL
and	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
with	NULL
the	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
MZF-1	NULL
represses	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
and	NULL
activates	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

Activation	NULL
of	NULL
CD34	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
intact	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
cell	NULL
type-specific	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
by	NULL
MZF-1	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
tissue-specific	NULL
regulators/	NULL
adapters	NULL
or	NULL
differential	NULL
MZF-1	NULL
modifications	NULL
that	NULL
determine	NULL
MZF-1	NULL
transcriptional	NULL
regulatory	NULL
function	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

are	NULL
either	NULL
activated	NULL
or	NULL
deactivated	NULL
to	NULL
alter	NULL
the	NULL
pattern	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Transcription	NULL
factors	NULL
have	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
translating	NULL
the	NULL
cell	NULL
surface	NULL
signal	NULL
into	NULL
a	NULL
specific	NULL
pathway	NULL
of	NULL
differentiation	NULL
by	NULL
specifying	NULL
which	NULL
genes	NULL
will	NULL
be	NULL
actively	NULL
used	NULL
by	NULL
a	NULL
cell	NULL
at	NULL
a	NULL
particular	NULL
time	NULL
in	NULL
development	NULL
.	NULL
``	NULL

''	NULL
Transcriptional	NULL
regulators	NULL
can	NULL
be	NULL
classified	NULL
into	NULL
families	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
distinct	NULL
structural/functional	NULL
domains	NULL
characterized	NULL
by	NULL
conserved	NULL
amino	NULL
acid	NULL
sequences	NULL
.	NULL

*	NULL
``	NULL
Zinc	NULL
finger	NULL
genes	NULL
'	NULL
represent	NULL
one	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
form	NULL
such	NULL
a	NULL
domain	NULL
when	NULL
the	NULL
conserved	NULL
amino	NULL
acids	NULL
cysteine	NULL
and	NULL
histidine	NULL
bind	NULL
a	NULL
central	NULL
zinc	NULL
ion	NULL
.	NULL

Zinc	NULL
finger	NULL
genes	NULL
can	NULL
be	NULL
further	NULL
classified	NULL
by	NULL
their	NULL
finger	NULL
domain	NULL
structures	NULL
.	NULL

The	NULL
C2H2	NULL
zinc	NULL
finger	NULL
family	NULL
,	NULL
exemplified	NULL
by	NULL
Krupple	NULL
,	NULL
a	NULL
Drosophila	NULL
gap	NULL
gene	NULL
,	NULL
``	NULL
contains	NULL
the	NULL
highly	NULL
conserved	NULL
peptide	NULL
motif	NULL
CX2CX3FX5LX2HX3H	NULL
.	NULL

Zinc	NULL
fingers	NULL
usually	NULL
occur	NULL
in	NULL
repeats	NULL
,	NULL
and	NULL
individual	NULL
fingers	NULL
are	NULL
separated	NULL
by	NULL
a	NULL
conserved	NULL
region	NULL
called	NULL
the	NULL
H-C	NULL
link	NULL
.	NULL

The	NULL
Krupple	NULL
family	NULL
members	NULL
usually	NULL
contain	NULL
the	NULL
H-C	NULL
link	NULL
motif	NULL
of	NULL
TGEKPYX	NULL
.	NULL

Many	NULL
members	NULL
of	NULL
the	NULL
C2H2	NULL
zinc	NULL
finger	NULL
gene	NULL
family	NULL
regulate	NULL
differentiation	NULL
processes	NULL
,	NULL
and	NULL
genetic	NULL
mutations	NULL
in	NULL
some	NULL
zinc	NULL
finger	NULL
genes	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
specific	NULL
human	NULL
dis-eases	NULL
.	NULL
``	NULL

The	NULL
myeloid	NULL
zinc	NULL
finger	NULL
gene	NULL
1	NULL
,	NULL
MZF-1	NULL
,	NULL
is	NULL
a	NULL
putative	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
C2H2	NULL
zinc	NULL
finger	NULL
gene	NULL
family	NULL
.	NULL

MZF-1	NULL
was	NULL
cloned	NULL
from	NULL
the	NULL
peripheral	NULL
leukocytes	NULL
isolated	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia®	NULL
and	NULL
exhibits	NULL
several	NULL
characteristics	NULL
suggesting	NULL
that	NULL
MZF-1	NULL
is	NULL
a	NULL
necessary	NULL
factor	NULL
for	NULL
granulocytic	NULL
differentiation	NULL
.	NULL
``	NULL

MZF-1	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
and	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
from	NULL
normal	NULL
marrow	NULL
.	NULL
``	NULL

''	NULL
In	NULL
addition	NULL
,	NULL
antisense	NULL
,	NULL
but	NULL
not	NULL
sense	NULL
,	NULL
oligonucleotides	NULL
markedly	NULL
inhibit	NULL
in	NULL
vitro	NULL
granulocyte	NULL
but	NULL
not	NULL
erythrocyte	NULL
colony	NULL
forma-tion	NULL
.	NULL
``	NULL

To	NULL
define	NULL
the	NULL
role	NULL
of	NULL
MZF-1	NULL
in	NULL
regulating	NULL
myeloid	NULL
differentiation	NULL
,	NULL
we	NULL
have	NULL
initiated	NULL
a	NULL
comprehensive	NULL
molecular	NULL
,	NULL
cel-	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
10	NULL
(	NULL
November	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
3640-3647	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MZF-1	NULL
REGULATES	NULL
CD34	NULL
MZF1	NULL
Fig	NULL
1	NULL
.	NULL

Schematic	NULL
of	NULL
the	NULL
MZF-1	NULL
protein	NULL
and	NULL
its	NULL
peptide	NULL
domains	NULL
.	NULL

The	NULL
MZF-1	NULL
protein	NULL
has	NULL
13	NULL
zinc	NULL
fin-	NULL
-	NULL
;	NULL
ZN	NULL
1-4	NULL
ger	NULL
domains	NULL
(	NULL
ZN	NULL
1-4	NULL
and	NULL
ZN	NULL
5-13	NULL
)	NULL
separated	NULL
into	NULL
two	NULL
sections	NULL
by	NULL
a	NULL
glycine-proline	NULL
rich	NULL
region	NULL
.	NULL

There	NULL
is	NULL
an	NULL
ZN	NULL
5413	NULL
acidic	NULL
region	NULL
in	NULL
the	NULL
5¢	NULL
portion	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

lular	NULL
,	NULL
and	NULL
biochemical	NULL
characterization	NULL
.	NULL

MZF-1	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
13	NULL
C2H2	NULL
zinc	NULL
fingers	NULL
arranged	NULL
in	NULL
two	NULL
DNA	NULL
binding	NULL
domains	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
identified	NULL
the	NULL
core	NULL
DNA	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
each	NULL
of	NULL
the	NULL
two	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL
``	NULL

The	NULL
first	NULL
domain	NULL
of	NULL
fingers	NULL
1-4	NULL
(	NULL
ZN	NULL
1-4	NULL
)	NULL
binds	NULL
to	NULL
the	NULL
core	NULL
sequence	NULL
and	NULL
the	NULL
second	NULL
domain	NULL
of	NULL
fingers	NULL
5-13	NULL
(	NULL
ZN	NULL
5-13	NULL
)	NULL
binds	NULL
the	NULL
core	NULL
sequence	NULL
5-CGGGnGAGGGGGAA-3	NULL
'	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
MZF-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
several	NULL
genes	NULL
that	NULL
are	NULL
differentially	NULL
expressed	NULL
during	NULL
myeloid	NULL
differentiation	NULL
,	NULL
including	NULL
CD34	NULL
.	NULL

This	NULL
present	NULL
study	NULL
found	NULL
that	NULL
MZPF-1	NULL
regulated	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

-	NULL
All	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
NIH	NULL
3T3	NULL
(	NULL
murine	NULL
embryonic	NULL
fibroblast	NULL
)	NULL
,	NULL
293	NULL
(	NULL
human	NULL
adenovirus-transformed	NULL
kidney	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
Hela	NULL
(	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
plus	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
K562	NULL
(	NULL
human	NULL
erythroleuke-mia	NULL
from	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
human	NULL
acute	NULL
T-cell	NULL
leukemia	NULL
)	NULL
,	NULL
and	NULL
KG-1	NULL
(	NULL
human	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
plus	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

Hela	NULL
,	NULL
NIH	NULL
3T3	NULL
,	NULL
293	NULL
,	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
do	NULL
not	NULL
express	NULL
MZF-1	NULL
,	NULL
and	NULL
the	NULL
K562	NULL
and	NULL
KG-1	NULL
cells	NULL
express	NULL
MZEF-1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
KG-1	NULL
cells	NULL
are	NULL
CD34*	NULL
,	NULL
whereas	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
do	NULL
not	NULL
express	NULL
CD34	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
cell	NULL
lines	NULL
represent	NULL
the	NULL
possible	NULL
variations	NULL
in	NULL
phenotype	NULL
needed	NULL
to	NULL
test	NULL
MZF-1	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
this	NULL
study	NULL
,	NULL
ie	NULL
nonhematopoietic	NULL
and	NULL
hematopoietic	NULL
,	NULL
MZF-1	NULL
expressing	NULL
and	NULL
nonexpressing	NULL
,	NULL
and	NULL
CD34*	NULL
and	NULL
CD34~	NULL
.	NULL

GALA	NULL
assays	NULL
.	NULL

Chimeric	NULL
proteins	NULL
were	NULL
produced	NULL
that	NULL
fuse	NULL
the	NULL
yeast	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
to	NULL
the	NULL
full-length	NULL
MZF-1	NULL
protein	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Full-length	NULL
MZF-1	NULL
was	NULL
used	NULL
because	NULL
the	NULL
zinc	NULL
finger	NULL
domains	NULL
may	NULL
have	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
that	NULL
would	NULL
be	NULL
masked	NULL
if	NULL
they	NULL
were	NULL
deleted	NULL
.	NULL

The	NULL
coding	NULL
region	NULL
of	NULL
MZF-1	NULL
was	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
-amplified	NULL
using	NULL
a	NULL
sense	NULL
oligonucleotide	NULL
that	NULL
inserts	NULL
an	NULL
EcoRI	NULL
restriction	NULL
enzyme	NULL
site	NULL
(	NULL
5'-TTATAGAATTCA-TGAATGGTCCCCTT-3	NULL
'	NULL
)	NULL
and	NULL
an	NULL
antisense	NULL
oligonucleotide	NULL
that	NULL
inserts	NULL
an	NULL
Xba	NULL
I	NULL
restriction	NULL
site	NULL
(	NULL
5'-TCACTGGTCTAGACTACTCGG-CGCTGTG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
the	NULL
restriction	NULL
enzymes	NULL
EcoRI	NULL
and	NULL
Xba	NULL
I	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
GALA	NULL
expression	NULL
plasmid	NULL
pSG424	NULL
``	NULL
to	NULL
produce	NULL
a	NULL
GAL4-MZF	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
entire	NULL
MZF-1	NULL
coding	NULL
region	NULL
3	NULL
'	NULL
of	NULL
the	NULL
GALA	NULL
zinc	NULL
finger	NULL
region	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
construct	NULL
was	NULL
confirmed	NULL
using	NULL
dideoxy	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
GAL4-MZF-1	NULL
fusion	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
pGAL4-5/tk-CAT	NULL
,	NULL
containing	NULL
5	NULL
GAL4	NULL
binding	NULL
sites	NULL
preceding	NULL
the	NULL
minimal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
regulating	NULL
expression	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
gene	NULL
.	NULL
``	NULL

The	NULL
GAL4	NULL
binding	NULL
sites	NULL
are	NULL
distinct	NULL
from	NULL
the	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
reporter	NULL
construct	NULL
had	NULL
a	NULL
modest	NULL
basal	NULL
activation	NULL
3641	NULL
ACIDIC	NULL
REGION	NULL
GLYCINEPROLINE	NULL
RICH	NULL
REGION	NULL
l	NULL
AMINO	NULL
ACIDS	NULL
r	NULL
]	NULL
Plzuﬁu	NULL
[	NULL
z-	NULL
I	NULL
``	NULL
lll	NULL
|zn	NULL
11-15	NULL
[	NULL
zn	NULL
[	NULL
ll	NULL
[	NULL
NM	NULL
1-485	NULL
msronmnnHn	NULL
[	NULL
2m	NULL
[	NULL
zn	NULL
[	NULL
zm	NULL
[	NULL
zn	NULL
]	NULL
108-240	NULL
218-485	NULL
wan	NULL
ous	NULL
,	NULL
,	NULL
,	NULL
[	NULL
2m	NULL
[	NULL
zw	NULL
[	NULL
2m	NULL
Jom	NULL
[	NULL
zw	NULL
Jz	NULL
few	NULL
zi	NULL
[	NULL
2	NULL
|	NULL
rate	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
for	NULL
these	NULL
studies	NULL
and	NULL
was	NULL
therefore	NULL
used	NULL
for	NULL
both	NULL
activation	NULL
and	NULL
repression	NULL
studies	NULL
.	NULL

This	NULL
allowed	NULL
a	NULL
more	NULL
direct	NULL
comparison	NULL
of	NULL
the	NULL
activation	NULL
seen	NULL
in	NULL
hematopoietic	NULL
lines	NULL
compared	NULL
with	NULL
the	NULL
repression	NULL
seen	NULL
in	NULL
nonhematopoietic	NULL
lines	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
measured	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
36	NULL
hours	NULL
after	NULL
transfection	NULL
.	NULL

CD34	NULL
promoter	NULL
assays	NULL
.	NULL

-	NULL
A	NULL
1.2-kb	NULL
BamHI-Sac	NULL
I	NULL
DNA	NULL
fragment	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
(	NULL
-1.1	NULL
to	NULL
+78	NULL
from	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
according	NULL
to	NULL
He	NULL
et	NULL
al	NULL
``	NULL
``	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
KS+	NULL
.	NULL

The	NULL
reporter	NULL
fragment	NULL
was	NULL
then	NULL
excised	NULL
and	NULL
subcloned	NULL
onto	NULL
the	NULL
BamHI-Sac	NULL
I	NULL
sites	NULL
of	NULL
pGL2Basic	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
to	NULL
create	NULL
the	NULL
CD34	NULL
luciferase	NULL
reporter	NULL
construct	NULL
``	NULL
(	NULL
here	NULL
termed	NULL
CD34-Luc	NULL
)	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
three	NULL
MZF-1	NULL
DNA	NULL
binding	NULL
sites	NULL
.	NULL

These	NULL
three	NULL
sites	NULL
,	NULL
termed	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
are	NULL
at	NULL
-584	NULL
,	NULL
-516	NULL
,	NULL
and	NULL
-148	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

``	NULL
*	NULL
As	NULL
shown	NULL
below	NULL
,	NULL
the	NULL
core	NULL
guanines	NULL
in	NULL
these	NULL
three	NULL
MZF-1	NULL
binding	NULL
sites	NULL
were	NULL
mutated	NULL
to	NULL
thymines	NULL
using	NULL
the	NULL
PCR-based	NULL
overlap	NULL
extension	NULL
method	NULL
.	NULL
``	NULL

''	NULL
The	NULL
CD34	NULL
promoter	NULL
construct	NULL
with	NULL
the	NULL
three	NULL
MZF-1	NULL
sites	NULL
mutated	NULL
(	NULL
termed	NULL
CD34-ABC	NULL
)	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
the	NULL
binding	NULL
site-dependence	NULL
of	NULL
MZF-1	NULL
regulation	NULL
of	NULL
CD34	NULL
.	NULL

Site	NULL
A	NULL
:	NULL
wild-type	NULL
,	NULL
5-CTGGAGAGGGGATAACTG-GGGA-3	NULL
'	NULL
;	NULL
mutant	NULL
,	NULL
5-CTGGATATTTTATATTTITA-3	NULL
'	NULL
.	NULL

Site	NULL
B	NULL
:	NULL
wild-type	NULL
,	NULL
5	NULL
!	NULL

-ATGGTGATGGGGAACTAAATGGGGA-3	NULL
'	NULL
;	NULL
mutant	NULL
,	NULL
-	NULL
5'-ATGGTGATTTTITAACTAAAATTTTTTA-3	NULL
'	NULL
.	NULL

Site	NULL
C	NULL
:	NULL
wild-type	NULL
,	NULL
5-AGTGGGGA-3	NULL
'	NULL
;	NULL
mutant	NULL
,	NULL
5'-AGTTTTTA-3	NULL
'	NULL
.	NULL

Sites	NULL
A	NULL
and	NULL
B	NULL
have	NULL
DNA	NULL
sequences	NULL
that	NULL
contain	NULL
the	NULL
full-length	NULL
MZEF-1	NULL
binding	NULL
sites	NULL
composed	NULL
of	NULL
the	NULL
sequences	NULL
recognized	NULL
by	NULL
ZN	NULL
1-4	NULL
and	NULL
ZN	NULL
5-13	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Site	NULL
C	NULL
has	NULL
only	NULL
a	NULL
single	NULL
ZN1-4	NULL
binding	NULL
site	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
binding	NULL
site	NULL
selection	NULL
studies	NULL
,	NULL
MZF-1	NULL
will	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
mutated	NULL
sites	NULL
.	NULL
``	NULL

The	NULL
entire	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
MZF-1	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
CB6	NULL
,	NULL
'	NULL
``	NULL
where	NULL
the	NULL
cDNA	NULL
is	NULL
driven	NULL
off	NULL
the	NULL
CMV	NULL
IE	NULL
promoter	NULL
.	NULL
``	NULL

This	NULL
vector	NULL
,	NULL
termed	NULL
CB6-MZF	NULL
,	NULL
was	NULL
used	NULL
in	NULL
the	NULL
cotransfection	NULL
studies	NULL
with	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

A	NULL
-|	NULL
SV40p	NULL
HEM	NULL
;	NULL
14147	NULL
|	NULL
MZF-1	NULL
Hsvm	NULL
PA	NULL
|	NULL
Fig	NULL
2	NULL
.	NULL

Schematic	NULL
of	NULL
the	NULL
GAL4-MZF	NULL
fusion	NULL
expression	NULL
vector	NULL
.	NULL

Amino	NULL
acids	NULL
1-147	NULL
from	NULL
the	NULL
GAL4	NULL
zinc	NULL
finger	NULL
gene	NULL
,	NULL
containing	NULL
the	NULL
DNA	NULL
binding	NULL
segment	NULL
,	NULL
were	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
MZF-1	NULL
.	NULL

Because	NULL
some	NULL
transcriptional	NULL
regulatory	NULL
domains	NULL
are	NULL
influenced	NULL
by	NULL
DNA	NULL
binding	NULL
domains	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
MZF-1	NULL
was	NULL
left	NULL
intact	NULL
.	NULL

GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
are	NULL
distinct	NULL
from	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
cDNA	NULL
was	NULL
driven	NULL
off	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
(	NULL
SV40p	NULL
)	NULL
,	NULL
with	NULL
the	NULL
SV40	NULL
termination	NULL
and	NULL
polyadenylation	NULL
signals	NULL
(	NULL
SV40	NULL
pA	NULL
)	NULL
placed	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
of	NULL
the	NULL
GAL4-tk/CAT	NULL
reporter	NULL
construct	NULL
.	NULL

Five	NULL
GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
(	NULL
GAL4/5	NULL
)	NULL
were	NULL
placed	NULL
5	NULL
'	NULL
to	NULL
a	NULL
truncated	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
TK	NULL
)	NULL
driving	NULL
the	NULL
chloramphenicol	NULL
acetylitransferase	NULL
cDNA	NULL
(	NULL
CAT	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3642	NULL
1.0	NULL
-	NULL
”	NULL
j	NULL
1-3	NULL
z	NULL
9.87	NULL
o	NULL
&	NULL
U	NULL
it	NULL
&	NULL
NH	NULL
[	NULL
+4	NULL
[	NULL
=	NULL
]	NULL
a	NULL
n	NULL
o.4-|	NULL
0.2	NULL
293	NULL
arts	NULL
50	NULL
40	NULL
Z	NULL
o	NULL
2	NULL
30	NULL
<	NULL
A	NULL
o	NULL
4	NULL
ap	NULL
10	NULL
ﬂ	NULL
t	NULL
--	NULL
--	NULL
i	NULL
--	NULL
--	NULL
4	NULL
K562	NULL
JURKAT	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
GAL4	NULL
assays	NULL
to	NULL
assess	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
of	NULL
MZF-1	NULL
.	NULL

MZF-1	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
cotransfected	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
construct	NULL
with	NULL
five	NULL
GAL4	NULL
binding	NULL
sites	NULL
in	NULL
front	NULL
of	NULL
the	NULL
thymine	NULL
kinase	NULL
promoter	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
GAL4	NULL
expression	NULL
vector	NULL
alone	NULL
,	NULL
without	NULL
MZF-1	NULL
,	NULL
is	NULL
proportional	NULL
to	NULL
the	NULL
transcriptional	NULL
activity	NULL
conferred	NULL
by	NULL
MZF-1	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
.	NULL

In	NULL
the	NULL
nonhematopoietic	NULL
cells	NULL
3T3	NULL
and	NULL
293	NULL
,	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
conferred	NULL
by	NULL
GAL4-MZF	NULL
as	NULL
compared	NULL
with	NULL
GAL4	NULL
alone	NULL
was	NULL
markedly	NULL
decreased	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
repression	NULL
.	NULL

Because	NULL
GAL4-MZF	NULL
activated	NULL
reporter	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
hematopoietic	NULL
lines	NULL
K562	NULL
and	NULL
Jurkat	NULL
,	NULL
the	NULL
data	NULL
were	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
.	NULL

CAT	NULL
activity	NULL
from	NULL
conferred	NULL
by	NULL
GAL4	NULL
alone	NULL
was	NULL
normalized	NULL
to	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
for	NULL
both	NULL
nonhematopoietic	NULL
and	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
,	NULL
Each	NULL
data	NULL
point	NULL
represents	NULL
the	NULL
average	NULL
+	NULL
the	NULL
standard	NULL
error	NULL
{	NULL
SEM	NULL
)	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
cotransfections	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
the	NULL
standard	NULL
error	NULL
is	NULL
approximately	NULL
the	NULL
size	NULL
of	NULL
the	NULL
line	NULL
representing	NULL
the	NULL
average	NULL
and	NULL
is	NULL
therefore	NULL
not	NULL
given	NULL
an	NULL
error	NULL
bar	NULL
.	NULL

(	NULL
0	NULL
)	NULL
0	NULL
ug	NULL
GAL4-MZF	NULL
;	NULL
(	NULL
I	NULL
)	NULL
5	NULL
ug	NULL
GAL4-MZF	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
recombinant	NULL
MZF-1	NULL
protein	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
three	NULL
sites	NULL
in	NULL
the	NULL
CD34	NULL
promoter	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Recombinant	NULL
MZF-1	NULL
protein	NULL
was	NULL
synthesized	NULL
using	NULL
the	NULL
histidine-containing	NULL
pDS56	NULL
expression	NULL
vector	NULL
and	NULL
recombinant	NULL
protein	NULL
isolated	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
nickel-agarose	NULL
MORRIS	NULL
ET	NULL
AL	NULL
column	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
1.2-kb	NULL
BamHI-Suc	NULL
I	NULL
CD34	NULL
promoter	NULL
fragment	NULL
was	NULL
digested	NULL
to	NULL
completion	NULL
with	NULL
the	NULL
restriction	NULL
enzyme	NULL
Mse	NULL
I	NULL
and	NULL
end-labeled	NULL
with	NULL
the	NULL
large	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
and	NULL
a	NULL
``	NULL
P-dATP	NULL
.	NULL

Mse	NULL
I	NULL
digestion	NULL
of	NULL
the	NULL
1.2-kb	NULL
DNA	NULL
fragment	NULL
produced	NULL
DNA	NULL
fragments	NULL
of	NULL
75	NULL
to	NULL
600	NULL
nucleotides	NULL
.	NULL

The	NULL
600-bp	NULL
fragment	NULL
contains	NULL
both	NULL
the	NULL
A	NULL
and	NULL
B	NULL
MZF-1	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
97-bp	NULL
fragment	NULL
contains	NULL
site	NULL
C.	NULL
Consensus	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
MZF-1	NULL
were	NULL
previously	NULL
isolated	NULL
,	NULL
``	NULL
'	NULL
and	NULL
duplex	NULL
oligomers	NULL
from	NULL
these	NULL
sites	NULL
were	NULL
used	NULL
to	NULL
compete	NULL
binding	NULL
of	NULL
recombinant	NULL
MZF1	NULL
to	NULL
a	NULL
234-bp	NULL
CD34	NULL
promoter	NULL
fragment	NULL
containing	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
(	NULL
~653	NULL
to	NULL
-419	NULL
,	NULL
according	NULL
to	NULL
He	NULL
et	NULL
al	NULL
``	NULL
``	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
obtained	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
primers	NULL
5-GTGGAGGATGGAGT-3	NULL
'	NULL
and	NULL
5'-TTCCCTGCAAGACC-3	NULL
'	NULL
,	NULL
with	NULL
the	NULL
CD34-Luc	NULL
as	NULL
template	NULL
.	NULL

Transfection	NULL
analysis	NULL
.	NULL

The	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
using	NULL
Lipofectin	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
BRL	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
}	NULL
.	NULL

Log	NULL
phase	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
10°	NULL
per	NULL
100-mm	NULL
culture	NULL
dish	NULL
and	NULL
incubated	NULL
overnight	NULL
.	NULL

Six	NULL
hours	NULL
before	NULL
transfection	NULL
,	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
scraping	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
phos-phate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
by	NULL
3	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
0.25	NULL
mol/L	NULL
Tris-HCi	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mmol/L	NULL
phenyImethyIsufonyl	NULL
fluoride	NULL
,	NULL
1	NULL
ug/	NULL
mL	NULL
of	NULL
pepstatin	NULL
A	NULL
,	NULL
and	NULL
1	NULL
g/mL	NULL
of	NULL
leupeptin	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
assessed	NULL
for	NULL
CAT	NULL
activity	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
KG-1	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
a	NULL
Bio-Rad	NULL
(	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
electroporator	NULL
at	NULL
0.24	NULL
kV	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

Briefly	NULL
,	NULL
log	NULL
phase	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
fresh	NULL
media	NULL
overnight	NULL
,	NULL
and	NULL
then	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
0.4	NULL
mL	NULL
were	NULL
placed	NULL
in	NULL
a	NULL
cuvette	NULL
with	NULL
the	NULL
appropriate	NULL
plasmids	NULL
.	NULL

Cuvettes	NULL
were	NULL
allowed	NULL
to	NULL
sit	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
minutes	NULL
before	NULL
and	NULL
after	NULL
electroporation	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
placed	NULL
in	NULL
5	NULL
mL	NULL
of	NULL
media	NULL
for	NULL
12	NULL
hours	NULL
before	NULL
lysate	NULL
preparation	NULL
.	NULL

Lysate	NULL
preparation	NULL
were	NULL
identical	NULL
to	NULL
that	NULL
for	NULL
nonhematopoietic	NULL
cells	NULL
described	NULL
above	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

''	NULL
``	NULL
'	NULL
The	NULL
quantity	NULL
of	NULL
expression	NULL
vector	NULL
or	NULL
reporter	NULL
construct	NULL
was	NULL
varied	NULL
as	NULL
required	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
to	NULL
maintain	NULL
CAT	NULL
or	NULL
luciferase	NULL
values	NULL
within	NULL
their	NULL
respective	NULL
linear	NULL
ranges	NULL
.	NULL

When	NULL
needed	NULL
,	NULL
empty	NULL
vector	NULL
was	NULL
added	NULL
to	NULL
maintain	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
by	NULL
transfecting	NULL
RSV-BGAL	NULL
,	NULL
a	NULL
-galactosidase	NULL
expression	NULL
vector	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
-galactosidase	NULL
activity	NULL
,	NULL
as	NULL
described	NULL
,	NULL
``	NULL
and	NULL
individual	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
performed	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
times	NULL
to	NULL
obtain	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
errors	NULL
.	NULL

RESULTS	NULL
Assessment	NULL
of	NULL
MZF-1	NULL
transcriptional	NULL
regulation	NULL
with	NULL
GALA	NULL
assays	NULL
.	NULL

MZF-1	NULL
belongs	NULL
to	NULL
the	NULL
Krupple	NULL
family	NULL
of	NULL
MZE-4	NULL
FULL	NULL
SiTe	NULL
MZF-1	NULL
HALF	NULL
site	NULL
200	NULL
0	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Schematic	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
The	NULL
MZF-1	NULL
full	NULL
sites	NULL
contain	NULL
sequences	NULL
nearly	NULL
identical	NULL
to	NULL
the	NULL
selected	NULL
consensus	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
ZN	NULL
1-4	NULL
and	NULL
ZN	NULL
5-13	NULL
.	NULL

The	NULL
MZF-1	NULL
half	NULL
site	NULL
contains	NULL
a	NULL
site	NULL
identical	NULL
to	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
site	NULL
for	NULL
ZN	NULL
1-4	NULL
.	NULL

The	NULL
Materials	NULL
and	NULL
Methods	NULL
contains	NULL
a	NULL
full	NULL
description	NULL
of	NULL
the	NULL
sequences	NULL
and	NULL
exact	NULL
location	NULL
of	NULL
the	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MZF-1	NULL
REGULATES	NULL
CD34	NULL
zinc	NULL
finger	NULL
genes	NULL
by	NULL
amino	NULL
acid	NULL
homology	NULL
.	NULL

The	NULL
members	NULL
of	NULL
this	NULL
family	NULL
that	NULL
have	NULL
been	NULL
biochemically	NULL
characterized	NULL
are	NULL
transcriptional	NULL
regulators	NULL
.	NULL
``	NULL

The	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
of	NULL
MZF-1	NULL
had	NULL
not	NULL
yet	NULL
been	NULL
proven	NULL
.	NULL

The	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
of	NULL
proteins	NULL
can	NULL
be	NULL
assessed	NULL
by	NULL
fusing	NULL
the	NULL
putative	NULL
regulatory	NULL
protein	NULL
domain	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
such	NULL
as	NULL
GAL4	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
MZF-1	NULL
was	NULL
a	NULL
transcriptional	NULL
activator	NULL
or	NULL
repressor	NULL
GAL4-MZF	NULL
was	NULL
cotransfected	NULL
with	NULL
pGAL4-5/tk-CAT	NULL
into	NULL
two	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
3T3	NULL
and	NULL
293	NULL
)	NULL
and	NULL
two	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
Jurkat	NULL
and	NULL
K562	NULL
)	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
is	NULL
provided	NULL
by	NULL
MZF-1	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
recognizing	NULL
the	NULL
reporter	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
GAL4	NULL
zinc	NULL
fingers	NULL
.	NULL

There	NULL
is	NULL
no	NULL
homology	NULL
between	NULL
the	NULL
GAL4	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
the	NULL
two	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
,	NULL
GALA-MZF-1	NULL
repressed	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

In	NULL
3T3	NULL
cells	NULL
,	NULL
GALA4-MZF	NULL
repressed	NULL
CAT	NULL
activity	NULL
an	NULL
average	NULL
of	NULL
17-fold	NULL
from	NULL
GAL4	NULL
alone	NULL
.	NULL

In	NULL
293	NULL
cells	NULL
,	NULL
with	NULL
the	NULL
same	NULL
transduction	NULL
procedure	NULL
,	NULL
GAL4-MZF	NULL
repressed	NULL
CAT	NULL
activity	NULL
by	NULL
an	NULL
average	NULL
of	NULL
3.3-fold	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
GAL4-MZF	NULL
behaved	NULL
differently	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
found	NULL
to	NULL
activate	NULL
CAT	NULL
expression	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

In	NULL
K562	NULL
cells	NULL
,	NULL
GAL4-MZF	NULL
increased	NULL
CAT	NULL
activity	NULL
by	NULL
an	NULL
average	NULL
of	NULL
12.3-fold	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
GAL4-MZF	NULL
increased	NULL
CAT	NULL
activity	NULL
an	NULL
average	NULL
of	NULL
31.0-fold	NULL
.	NULL

Therefore	NULL
,	NULL
based	NULL
on	NULL
these	NULL
assays	NULL
,	NULL
MZF-1	NULL
had	NULL
bifunctional	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
.	NULL

In	NULL
one	NULL
intracellular	NULL
environment	NULL
it	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
and	NULL
in	NULL
another	NULL
as	NULL
an	NULL
activator	NULL
.	NULL

MZF-1	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

Once	NULL
the	NULL
GAL4	NULL
studies	NULL
established	NULL
MZF-1	NULL
as	NULL
a	NULL
transcriptional	NULL
regula-tor	NULL
,	NULL
myeloid	NULL
promoters	NULL
were	NULL
searched	NULL
for	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

Whereas	NULL
single	NULL
MZF-1	NULL
DNA	NULL
binding	NULL
sites	NULL
were	NULL
found	NULL
in	NULL
the	NULL
lactoferrin	NULL
and	NULL
myeloperoxidase	NULL
promoter	NULL
,	NULL
three	NULL
MZF1	NULL
binding	NULL
sites	NULL
(	NULL
called	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
;	NULL
Fig	NULL
4	NULL
)	NULL
were	NULL
found	NULL
within	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

The	NULL
CD34	NULL
promoter	NULL
was	NULL
chosen	NULL
for	NULL
further	NULL
analysis	NULL
based	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
multiple	NULL
MZF-1	NULL
binding	NULL
sites	NULL
,	NULL
making	NULL
it	NULL
a	NULL
strong	NULL
candidate	NULL
for	NULL
regulation	NULL
by	NULL
MZF-1	NULL
.	NULL

To	NULL
evaluate	NULL
recombinant	NULL
MZF-1	NULL
protein	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
,	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

MZF-1	NULL
bound	NULL
to	NULL
fragments	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
produced	NULL
by	NULL
Mse	NULL
I	NULL
restriction	NULL
digestion	NULL
containing	NULL
each	NULL
of	NULL
these	NULL
sites	NULL
.	NULL

The	NULL
600-bp	NULL
Mse	NULL
I	NULL
fragment	NULL
contained	NULL
two	NULL
MZF-1	NULL
binding	NULL
sites	NULL
,	NULL
termed	NULL
A	NULL
and	NULL
B	NULL
,	NULL
that	NULL
contained	NULL
DNA	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
zinc	NULL
finger	NULL
domains	NULL
1	NULL
through	NULL
4	NULL
and	NULL
5	NULL
through	NULL
13	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Recombinant	NULL
MZF-1	NULL
protein	NULL
fragments	NULL
containing	NULL
either	NULL
zinc	NULL
fingers	NULL
1	NULL
through	NULL
4	NULL
or	NULL
5	NULL
through	NULL
13	NULL
could	NULL
bind	NULL
to	NULL
this	NULL
CD34	NULL
fragment	NULL
.	NULL

A	NULL
smaller	NULL
Mse	NULL
I	NULL
fragment	NULL
of	NULL
97	NULL
bp	NULL
contained	NULL
a	NULL
binding	NULL
site	NULL
that	NULL
was	NULL
the	NULL
exact	NULL
consensus	NULL
for	NULL
MZF-1	NULL
zinc	NULL
fingers	NULL
1	NULL
through	NULL
4	NULL
.	NULL

This	NULL
DNA	NULL
fragment	NULL
also	NULL
bound	NULL
recombinant	NULL
MZF-1	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
MZF-1	NULL
binding	NULL
to	NULL
a	NULL
234-bp	NULL
PCR	NULL
fragment	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
containing	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
could	NULL
be	NULL
specifically	NULL
competed	NULL
with	NULL
the	NULL
cold	NULL
duplex	NULL
oligomers	NULL
containing	NULL
the	NULL
consensus	NULL
MZF-1	NULL
DNA	NULL
binding	NULL
sites	NULL
as	NULL
identified	NULL
3643	NULL
A	NULL
AB	NULL
>	NULL
C	NULL
>	NULL
B	NULL
Protein	NULL
:	NULL
rZN1-4	NULL
rZN5-13	NULL
Competitor	NULL
:	NULL
A	NULL
A	NULL
Probe	NULL
:	NULL
AB	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mobility	NULL
shift	NULL
assays	NULL
of	NULL
MZF-1	NULL
binding	NULL
to	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

MZF-1	NULL
can	NULL
bind	NULL
to	NULL
three	NULL
sites	NULL
(	NULL
termed	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
within	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

The	NULL
CD34-radiolabeled	NULL
fragments	NULL
containing	NULL
these	NULL
three	NULL
sites	NULL
are	NULL
designated	NULL
by	NULL
arrows	NULL
.	NULL

It	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
recombinant	NULL
MZF-1	NULL
protein	NULL
,	NULL
either	NULL
ZN1-4	NULL
or	NULL
ZN	NULL
5-13	NULL
,	NULL
can	NULL
bind	NULL
and	NULL
slow	NULL
the	NULL
gel	NULL
mobility	NULL
of	NULL
these	NULL
fragments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Recombinant	NULL
MZF-1	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
234-bp	NULL
CD34	NULL
promoter	NULL
fragment	NULL
containing	NULL
both	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
(	NULL
-653	NULL
to	NULL
-419	NULL
in	NULL
He	NULL
et	NULL
al	NULL
``	NULL
``	NULL
)	NULL
can	NULL
be	NULL
specifically	NULL
competed	NULL
with	NULL
the	NULL
duplex	NULL
oligomers	NULL
containing	NULL
the	NULL
consensus	NULL
MZF-1	NULL
ZN1-4	NULL
and	NULL
ZN5-13	NULL
binding	NULL
sites	NULL
identified	NULL
previously	NULL
.	NULL
``	NULL

The	NULL
bold	NULL
triangles	NULL
above	NULL
the	NULL
gel	NULL
photograph	NULL
represent	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
specific	NULL
duplex	NULL
oligomer	NULL
.	NULL

previously	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
MZF-1	NULL
protein	NULL
could	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
CD34	NULL
promoter	NULL
at	NULL
sequences	NULL
homologous	NULL
to	NULL
MZF-1	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
previously	NULL
described	NULL
pGL-basic	NULL
luciferase	NULL
reporter	NULL
under	NULL
control	NULL
of	NULL
the	NULL
1.2-kb	NULL
CD34	NULL
promoter	NULL
fragment	NULL
containing	NULL
all	NULL
three	NULL
MZF-1	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
MZF-1	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
CB6-MZF	NULL
with	NULL
this	NULL
CD34-luciferase	NULL
reporter	NULL
plasmid	NULL
``	NULL
(	NULL
here	NULL
termed	NULL
CD34-Luc	NULL
)	NULL
into	NULL
Hela	NULL
cells	NULL
repressed	NULL
luciferase	NULL
activity	NULL
by	NULL
an	NULL
average	NULL
of	NULL
5.2-fold	NULL
over	NULL
vector	NULL
alone	NULL
,	NULL
at	NULL
the	NULL
highest	NULL
CB6-MZF	NULL
level	NULL
.	NULL

In	NULL
3T3	NULL
cells	NULL
,	NULL
CB6-MZF	NULL
repressed	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3644	NULL
MORRIS	NULL
ET	NULL
AL	NULL
A	NULL
HeLa	NULL
C	NULL
KG1	NULL
1.0	NULL
-	NULL
ug	NULL
MZF-1	NULL
Vector	NULL
10.0	NULL
[	NULL
]	NULL
o	NULL
g	NULL
MZF-1	NULL
Vector	NULL
|	NULL
5	NULL
[	NULL
A	NULL
o	NULL
0	NULL
51	NULL
>	NULL
8.0-	NULL
G	NULL
10	NULL
z	NULL
6	NULL
~	NULL
5	NULL
4	NULL
3	NULL
w	NULL
T	NULL
oa	NULL
6.07	NULL
&	NULL
2	NULL
u	NULL
0.57	NULL
3	NULL
(	NULL
C	NULL
0	NULL
a	NULL
4	NULL
LL	NULL
a	NULL
4.0	NULL
O	NULL
LL	NULL
4	NULL
2.0	NULL
k	NULL
--	NULL
--	NULL
--	NULL
--	NULL
A	NULL
--	NULL
--	NULL
-3	NULL
ug	NULL
CD34	NULL
5	NULL
ug	NULL
CD34	NULL
10	NULL
ug	NULL
CD34	NULL
B	NULL
3T3	NULL
1.0	NULL
‘	NULL
1	NULL
g	NULL
MZF-1	NULL
Vector	NULL
[	NULL
J	NULL
]	NULL
0	NULL
Z	NULL
-	NULL
5	NULL
fer	NULL
0.8	NULL
§	NULL
is	NULL
W	NULL
A	NULL
l	NULL
£C	NULL
ﬁ	NULL
0.6	NULL
7	NULL
CC	NULL
Fig	NULL
6	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
a	NULL
CD34	NULL
promoter	NULL
by	NULL
MZF-1	NULL
.	NULL

The	NULL
-l	NULL
expression	NULL
vector	NULL
CBG-MZF	NULL
was	NULL
8	NULL
0.4	NULL
-	NULL
cotransfected	NULL
with	NULL
a	NULL
CD34-Luciferase	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
luciferase	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
vector	NULL
alone	NULL
is	NULL
a	NULL
0.2	NULL
-	NULL
measure	NULL
of	NULL
the	NULL
transcriptional	NULL
*	NULL
regulation	NULL
MZF-1	NULL
confers	NULL
.	NULL

In	NULL
nonhematopoietic	NULL
cells	NULL
(	NULL
[	NULL
A	NULL
]	NULL
Hela	NULL
and	NULL
[	NULL
B	NULL
]	NULL
313	NULL
)	NULL
,	NULL
MZF-1	NULL
represses	NULL
the	NULL
CD34	NULL
promoter	NULL
,	NULL
whereas	NULL
in	NULL
hematopoietic	NULL
cells	NULL
(	NULL
[	NULL
C	NULL
]	NULL
KG-1	NULL
,	NULL
F	NULL
|	NULL
[	NULL
D	NULL
]	NULL
Jurkat	NULL
,	NULL
and	NULL
[	NULL
E	NULL
]	NULL
K562	NULL
)	NULL
,	NULL
MZF-1	NULL
2	NULL
ugCD34	NULL
5	NULL
ugCD34	NULL
10	NULL
ugCD34	NULL
CD34-mediated	NULL
luciferase	NULL
activity	NULL
by	NULL
an	NULL
average	NULL
of	NULL
4.2-fold	NULL
.	NULL

This	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
GAL4	NULL
studies	NULL
.	NULL

MZF-1	NULL
functioned	NULL
as	NULL
a	NULL
repressor	NULL
when	NULL
transcription	NULL
was	NULL
initiated	NULL
by	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
MZF-1	NULL
activated	NULL
transcription	NULL
from	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
hematopoietic	NULL
cells	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
at	NULL
the	NULL
highest	NULL
transfected	NULL
amounts	NULL
of	NULL
CB6-MZF	NULL
,	NULL
CD34	NULL
luciferase	NULL
activity	NULL
was	NULL
increased	NULL
by	NULL
an	NULL
average	NULL
of	NULL
7.5-fold	NULL
.	NULL

In	NULL
K562	NULL
cells	NULL
at	NULL
similar	NULL
cotransfection	NULL
parameters	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
increased	NULL
by	NULL
an	NULL
average	NULL
of	NULL
18.1	NULL
-fold	NULL
.	NULL

In	NULL
KG-1	NULL
cells	NULL
,	NULL
the	NULL
average	NULL
increase	NULL
of	NULL
luciferase	NULL
activity	NULL
produced	NULL
by	NULL
CB6-	NULL
activates	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

MZF	NULL
was	NULL
6.1-fold	NULL
.	NULL

These	NULL
data	NULL
were	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
previously	NULL
described	NULL
GAL4	NULL
assays	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
three	NULL
MZF-1	NULL
binding	NULL
sites	NULL
in	NULL
CD34-Luc	NULL
abrogated	NULL
potential	NULL
MZF-1	NULL
interactions	NULL
;	NULL
CB6-MZF	NULL
no	NULL
longer	NULL
regulated	NULL
expression	NULL
of	NULL
CD34-mediated	NULL
transcription	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
and	NULL
K562	NULL
cells	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
CD34-ABC	NULL
by	NULL
CB6-MZF	NULL
was	NULL
reduced	NULL
to	NULL
that	NULL
of	NULL
CD34-Luc	NULL
baseline	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
first	NULL
portion	NULL
of	NULL
this	NULL
study	NULL
,	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
of	NULL
MZP-1	NULL
were	NULL
investigated	NULL
using	NULL
cotransfec-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MZF-1	NULL
REGULATES	NULL
CD34	NULL
3645	NULL
D	NULL
JURKAT	NULL
10.0	NULL
g	NULL
MZF-1	NULL
Vector	NULL
{	NULL
0	NULL
-	NULL
5	NULL
(	NULL
z	NULL
)	NULL
8.0	NULL
5	NULL
10	NULL
m	NULL
20	NULL
9	NULL
o	NULL
6.0	NULL
=	NULL
o	NULL
-l	NULL
2	NULL
4.0	NULL
2.0	NULL
k	NULL
--	NULL
--	NULL
--	NULL
A	NULL
--	NULL
-	NULL
--	NULL
-5	NULL
ug	NULL
CD34	NULL
10	NULL
ug	NULL
CD34	NULL
5	NULL
ug	NULL
CD34ABC	NULL
K562	NULL
20.0	NULL
1	NULL
10.0	NULL
-p-	NULL
Fig	NULL
6	NULL
.	NULL

(	NULL
Cont	NULL
'd	NULL
)	NULL
CD34-luc/	NULL
G5	NULL
8.0	NULL
ABC	NULL
indicates	NULL
the	NULL
CD34	NULL
reporter	NULL
a	NULL
construct	NULL
with	NULL
the	NULL
three	NULL
poten-	NULL
_	NULL
>	NULL
tial	NULL
MZF-1	NULL
binding	NULL
sites	NULL
mu-	NULL
a	NULL
6.0	NULL
tated	NULL
.	NULL

When	NULL
the	NULL
three	NULL
MZF-1	NULL
_	NULL
J	NULL
*	NULL
binding	NULL
sites	NULL
are	NULL
mutated	NULL
,	NULL
MZF-	NULL
9	NULL
1	NULL
loses	NULL
its	NULL
ability	NULL
to	NULL
regulate	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

All	NULL
transfections	NULL
4.0	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosi-	NULL
*	NULL
dase	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
CD34-Luc	NULL
-	NULL
cotransfected	NULL
-	NULL
with	NULL
empty	NULL
vector	NULL
DNA	NULL
was	NULL
given	NULL
a	NULL
2.0	NULL
value	NULL
of	NULL
1.0	NULL
,	NULL
and	NULL
all	NULL
values	NULL
from	NULL
the	NULL
MZF-1	NULL
expression	NULL
vector	NULL
co	NULL
transfections	NULL
were	NULL
compared	NULL
with	NULL
that	NULL
.	NULL

Each	NULL
data	NULL
point	NULL
repre-	NULL
ug	NULL
MZF-1	NULL
Vector	NULL
[	NULL
]	NULL
0	NULL
5	NULL
|=RDU	NULL
20	NULL
a	NULL
re	NULL
sents	NULL
the	NULL
average	NULL
+	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
cotransfections	NULL
.	NULL

tion	NULL
of	NULL
GAL4-MZF	NULL
fusion	NULL
proteins	NULL
and	NULL
GAL4	NULL
binding	NULL
site	NULL
reporter	NULL
plasmids	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
transcriptional	NULL
regulation	NULL
by	NULL
MZF-1	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
intracellular	NULL
environment	NULL
.	NULL

If	NULL
MZF-1	NULL
was	NULL
expressed	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
then	NULL
it	NULL
functioned	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

If	NULL
it	NULL
was	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
then	NULL
it	NULL
functioned	NULL
as	NULL
an	NULL
activator	NULL
.	NULL

This	NULL
surprising	NULL
finding	NULL
was	NULL
confirmed	NULL
in	NULL
several	NULL
different	NULL
types	NULL
of	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
variation	NULL
within	NULL
a	NULL
single	NULL
--	NULL
-I	NULL
I	NULL
--	NULL
--	NULL
10	NULL
ug	NULL
CD34	NULL
5	NULL
ug	NULL
CD34ABC	NULL
10	NULL
ug	NULL
CD34ABC	NULL
given	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
preliminary	NULL
experiments	NULL
,	NULL
MZF1	NULL
also	NULL
activated	NULL
a	NULL
reporter	NULL
construct	NULL
via	NULL
its	NULL
own	NULL
consensus	NULL
DNA	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
regulatory	NULL
activity	NULL
was	NULL
not	NULL
binding	NULL
site-specific	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
a	NULL
zinc	NULL
finger	NULL
gene	NULL
can	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
in	NULL
one	NULL
type	NULL
of	NULL
intracellular	NULL
environment	NULL
and	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
another	NULL
is	NULL
interesting	NULL
,	NULL
but	NULL
not	NULL
entirely	NULL
unique	NULL
.	NULL

There	NULL
is	NULL
preliminary	NULL
evidence	NULL
that	NULL
at	NULL
least	NULL
three	NULL
other	NULL
Krupple	NULL
class	NULL
zinc	NULL
finger	NULL
genes	NULL
may	NULL
also	NULL
have	NULL
bifunctional	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3646	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
Krupple	NULL
itself	NULL
can	NULL
activate	NULL
or	NULL
repress	NULL
transcription	NULL
depending	NULL
on	NULL
its	NULL
intracellular	NULL
concentration	NULL
.	NULL
``	NULL

YY1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
repress	NULL
transcription	NULL
from	NULL
the	NULL
adeno-associated	NULL
virus	NULL
P5	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
when	NULL
YY1	NULL
can	NULL
interact	NULL
with	NULL
adenovirus	NULL
E1A	NULL
,	NULL
it	NULL
mediates	NULL
activation	NULL
through	NULL
this	NULL
same	NULL
promoter	NULL
se-quence	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
Wilm	NULL
's	NULL
tumor	NULL
suppressor	NULL
zinc	NULL
finger	NULL
gene	NULL
WTI	NULL
can	NULL
also	NULL
mediate	NULL
repression	NULL
or	NULL
activa-tion	NULL
.	NULL
``	NULL

''	NULL
This	NULL
latter	NULL
case	NULL
is	NULL
more	NULL
similar	NULL
to	NULL
MZF-1	NULL
,	NULL
as	NULL
WTI	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
appear	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
which	NULL
cell	NULL
type	NULL
transcription	NULL
is	NULL
assessed	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
class	NULL
of	NULL
zinc	NULL
finger	NULL
genes	NULL
has	NULL
far	NULL
more	NULL
complex	NULL
regulatory	NULL
characteristics	NULL
than	NULL
previously	NULL
thought	NULL
.	NULL

The	NULL
second	NULL
portion	NULL
of	NULL
this	NULL
investigation	NULL
studied	NULL
the	NULL
binding	NULL
to	NULL
and	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
by	NULL
MZF-1	NULL
.	NULL

Recombinant	NULL
MZF-1	NULL
could	NULL
bind	NULL
to	NULL
sites	NULL
within	NULL
the	NULL
CD34	NULL
promoter	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Cotransfection	NULL
assays	NULL
showed	NULL
that	NULL
,	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
MZF-1	NULL
repressed	NULL
the	NULL
CD34	NULL
promoter	NULL
,	NULL
whereas	NULL
,	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
MZEF-1	NULL
activated	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL

This	NULL
was	NULL
entirely	NULL
consistent	NULL
with	NULL
the	NULL
GAL4	NULL
and	NULL
heterologous	NULL
promoter	NULL
studies	NULL
,	NULL
indicating	NULL
that	NULL
even	NULL
with	NULL
a	NULL
physiologically	NULL
relevant	NULL
promoter	NULL
such	NULL
as	NULL
CD34	NULL
MZF-1	NULL
still	NULL
had	NULL
bifunctional	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
.	NULL

The	NULL
hematopoietic-specific	NULL
activation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
occurred	NULL
in	NULL
cells	NULL
not	NULL
expressing	NULL
MZF1	NULL
or	NULL
CD34	NULL
(	NULL
Jurkat	NULL
)	NULL
,	NULL
cells	NULL
expressing	NULL
MZF-1	NULL
but	NULL
not	NULL
CD34	NULL
(	NULL
K562	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
expressing	NULL
both	NULL
MZF-1	NULL
and	NULL
CD34	NULL
(	NULL
KG-1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
appeared	NULL
dependent	NULL
on	NULL
whether	NULL
the	NULL
cell	NULL
was	NULL
of	NULL
hematopoietic	NULL
origin	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
three	NULL
MZF-1	NULL
binding	NULL
sites	NULL
,	NULL
because	NULL
mutation	NULL
of	NULL
these	NULL
three	NULL
sites	NULL
returned	NULL
CD34	NULL
expression	NULL
to	NULL
baseline	NULL
levels	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
contribution	NULL
of	NULL
each	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
whether	NULL
the	NULL
full	NULL
or	NULL
half-MZF	NULL
binding	NULL
sites	NULL
have	NULL
different	NULL
regulatory	NULL
roles	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
estab-lished	NULL
.	NULL

Still	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
MZF-1	NULL
mediates	NULL
transcription	NULL
through	NULL
binding	NULL
to	NULL
sequences	NULL
homologous	NULL
to	NULL
previously	NULL
defined	NULL
consensus	NULL
MZF-1	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
earlier	NULL
reports	NULL
we	NULL
described	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
CD34	NULL
promoter	NULL
had	NULL
activity	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
cells	NULL
not	NULL
of	NULL
hematopoietic	NULL
origin	NULL
.	NULL

Although	NULL
there	NULL
is	NULL
a	NULL
3	NULL
'	NULL
region	NULL
that	NULL
may	NULL
enhance	NULL
hematopoietic	NULL
specific	NULL
expression	NULL
of	NULL
CD34	NULL
,	NULL
``	NULL
there	NULL
are	NULL
probably	NULL
other	NULL
sequence	NULL
elements	NULL
not	NULL
yet	NULL
isolated	NULL
that	NULL
control	NULL
the	NULL
complete	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Other	NULL
regions	NULL
could	NULL
produce	NULL
silencing	NULL
of	NULL
the	NULL
gene	NULL
when	NULL
levels	NULL
of	NULL
CD34	NULL
decline	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
,	NULL
although	NULL
MZF-1	NULL
can	NULL
regulate	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
vitro	NULL
as	NULL
shown	NULL
here	NULL
,	NULL
proving	NULL
it	NULL
has	NULL
a	NULL
biologically	NULL
relevant	NULL
role	NULL
in	NULL
regulating	NULL
CD34	NULL
expression	NULL
in	NULL
marrow	NULL
progenitors	NULL
requires	NULL
more	NULL
definitive	NULL
analysis	NULL
,	NULL
such	NULL
as	NULL
a	NULL
knock-out	NULL
of	NULL
the	NULL
MZF-1	NULL
gene	NULL
.	NULL

It	NULL
is	NULL
also	NULL
quite	NULL
possible	NULL
that	NULL
MZF-1	NULL
is	NULL
just	NULL
a	NULL
part	NULL
of	NULL
the	NULL
complex	NULL
activation	NULL
of	NULL
the	NULL
CD34	NULL
promoter	NULL
;	NULL
there	NULL
may	NULL
easily	NULL
be	NULL
additional	NULL
activating	NULL
factors	NULL
in	NULL
the	NULL
appropriate	NULL
cells	NULL
.	NULL

Lending	NULL
evidence	NULL
to	NULL
this	NULL
view	NULL
is	NULL
another	NULL
study	NULL
that	NULL
found	NULL
that	NULL
c-myb	NULL
and	NULL
c-ets-2	NULL
also	NULL
activated	NULL
the	NULL
CD34	NULL
promoter	NULL
,	NULL
although	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL
``	NULL

C-ets-2	NULL
is	NULL
expressed	NULL
ubiqui-tously	NULL
,	NULL
whereas	NULL
c-myb	NULL
's	NULL
expression	NULL
pattern	NULL
resembles	NULL
MZF-1	NULL
.	NULL

There	NULL
are	NULL
sequences	NULL
within	NULL
the	NULL
CD34	NULL
promoter	NULL
that	NULL
are	NULL
MORRIS	NULL
ET	NULL
AL	NULL
homologous	NULL
to	NULL
ets	NULL
and	NULL
myb	NULL
binding	NULL
sites	NULL
.	NULL

How	NULL
c-ets-2	NULL
and	NULL
c-myb	NULL
might	NULL
interact	NULL
with	NULL
MZF-1	NULL
is	NULL
not	NULL
known	NULL
.	NULL

However	NULL
,	NULL
what	NULL
is	NULL
clear	NULL
is	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
CD34	NULL
gene	NULL
expression	NULL
is	NULL
multifactorial	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
MZF-1	NULL
is	NULL
a	NULL
general	NULL
myeloid	NULL
transcription	NULL
factor	NULL
.	NULL

Searches	NULL
of	NULL
other	NULL
myeloid	NULL
promoters	NULL
found	NULL
several	NULL
consensus	NULL
MZF-1	NULL
DNA	NULL
binding	NULL
sites	NULL
.	NULL

There	NULL
was	NULL
one	NULL
MZF1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
myeloperoxidase	NULL
promoter	NULL
at	NULL
-278	NULL
,	NULL
according	NULL
to	NULL
Morishita	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Recombinant	NULL
MZF-1	NULL
protein	NULL
will	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
in	NULL
a	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

There	NULL
was	NULL
one	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
human	NULL
lactoferrin	NULL
promoter	NULL
that	NULL
perfectly	NULL
matched	NULL
the	NULL
consensus	NULL
for	NULL
ZN1-4	NULL
at	NULL
-82	NULL
,	NULL
according	NULL
to	NULL
Johnston	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Recombinant	NULL
MZF-1	NULL
protein	NULL
will	NULL
also	NULL
bind	NULL
to	NULL
this	NULL
sequence	NULL
.	NULL

How	NULL
MZF-1	NULL
would	NULL
function	NULL
in	NULL
the	NULL
complex	NULL
regulation	NULL
of	NULL
these	NULL
promoters	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Both	NULL
lactoferrin	NULL
and	NULL
myeloperoxidase	NULL
are	NULL
expressed	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
myeloid	NULL
development	NULL
as	NULL
compared	NULL
with	NULL
CD34	NULL
.	NULL

However	NULL
,	NULL
MZF-1	NULL
is	NULL
expressed	NULL
during	NULL
the	NULL
stages	NULL
that	NULL
all	NULL
three	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
expressed	NULL
.	NULL
``	NULL

''	NULL
``	NULL
It	NULL
is	NULL
possible	NULL
that	NULL
MZF-1	NULL
may	NULL
function	NULL
as	NULL
a	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
activator	NULL
of	NULL
many	NULL
myeloid	NULL
genes	NULL
.	NULL

Stably	NULL
transfecting	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
MZF-1	NULL
into	NULL
nonmyeloid	NULL
cell	NULL
lines	NULL
and	NULL
assessing	NULL
myeloid	NULL
gene	NULL
transcription	NULL
may	NULL
answer	NULL
some	NULL
of	NULL
these	NULL
questions	NULL
.	NULL

Two	NULL
additional	NULL
features	NULL
of	NULL
MZF-1	NULL
add	NULL
other	NULL
dimensions	NULL
to	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
.	NULL

First	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
overex-pression	NULL
of	NULL
MZF-1	NULL
aggressively	NULL
transforms	NULL
3T3	NULL
cells	NULL
.	NULL
``	NULL

These	NULL
transformed	NULL
3T3	NULL
cells	NULL
traverse	NULL
the	NULL
cell	NULL
cycle	NULL
more	NULL
rapidly	NULL
,	NULL
form	NULL
foci	NULL
,	NULL
form	NULL
colonies	NULL
in	NULL
soft	NULL
agar	NULL
,	NULL
and	NULL
form	NULL
tumors	NULL
in	NULL
nude	NULL
mice	NULL
when	NULL
compared	NULL
with	NULL
control	NULL
3T3	NULL
cells	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
have	NULL
localized	NULL
the	NULL
5	NULL
end	NULL
of	NULL
MZF-1	NULL
to	NULL
within	NULL
12	NULL
kb	NULL
of	NULL
the	NULL
telomere	NULL
of	NULL
human	NULL
chromosome	NULL
19q	NULL
(	NULL
data	NULL
submitted	NULL
and	NULL
available	NULL
upon	NULL
request	NULL
)	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
,	NULL
in	NULL
primitive	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
,	NULL
the	NULL
telomeres	NULL
shorten	NULL
with	NULL
age	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
degeneration	NULL
of	NULL
aging	NULL
telomeres	NULL
may	NULL
disrupt	NULL
MZF-1	NULL
,	NULL
playing	NULL
a	NULL
role	NULL
in	NULL
the	NULL
increased	NULL
incidence	NULL
of	NULL
hematopoietic	NULL
dysfunction	NULL
seen	NULL
in	NULL
the	NULL
elderly	NULL
.	NULL

This	NULL
interesting	NULL
possibility	NULL
also	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
MZF-1	NULL
has	NULL
bifunctional	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
environment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
appears	NULL
to	NULL
regulate	NULL
the	NULL
CD34	NULL
promoter	NULL
through	NULL
specific	NULL
binding	NULL
sites	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
MZF1	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
governing	NULL
the	NULL
primitive	NULL
hematopoietic	NULL
phenotype	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Darnell	NULL
,	NULL
J	NULL
:	NULL
;	NULL
Variety	NULL
in	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
control	NULL
in	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Nature	NULL
297:365	NULL
,	NULL
1982	NULL
2	NULL
.	NULL

Groudine	NULL
M	NULL
,	NULL
Peretz	NULL
M	NULL
,	NULL
Weintraub	NULL
H	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
hemoglobin	NULL
switching	NULL
in	NULL
chicken	NULL
embryos	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
1:281	NULL
,	NULL
1981	NULL
3	NULL
.	NULL

McKnight	NULL
S	NULL
,	NULL
Palmiter	NULL
R	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
oval-albumin	NULL
and	NULL
conalbumin	NULL
genes	NULL
by	NULL
steroid	NULL
hormones	NULL
in	NULL
the	NULL
chick	NULL
oviduct	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
254:9050	NULL
,	NULL
1979	NULL
4	NULL
.	NULL

Hromas	NULL
R	NULL
,	NULL
Zon	NULL
L	NULL
,	NULL
Friedman	NULL
A	NULL
:	NULL
Hematopoietic	NULL
transcriptional	NULL
regulators	NULL
and	NULL
the	NULL
origins	NULL
of	NULL
leukemia	NULL
.	NULL

Crit	NULL
Rev	NULL
Oncol	NULL
Hematol	NULL
12:167	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

Johnson	NULL
PF	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
58:799	NULL
,	NULL
1989	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MZF-1	NULL
REGULATES	NULL
CD34	NULL
6	NULL
.	NULL

Mitchell	NULL
PJ	NULL
,	NULL
Tijan	NULL
R	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371	NULL
,	NULL
1989	NULL
7	NULL
.	NULL

Evans	NULL
R	NULL
,	NULL
Hollenberg	NULL
SM	NULL
:	NULL
Zinc	NULL
fingers	NULL
:	NULL
Gilt	NULL
by	NULL
association	NULL
.	NULL

Cell	NULL
52:1	NULL
,	NULL
1988	NULL
8	NULL
.	NULL

Schuh	NULL
R	NULL
,	NULL
Alcher	NULL
W	NULL
,	NULL
Gual	NULL
U	NULL
,	NULL
Cote	NULL
S	NULL
,	NULL
Preiss	NULL
A	NULL
,	NULL
Maier	NULL
D	NULL
,	NULL
Seifert	NULL
E	NULL
,	NULL
Nauber	NULL
U	NULL
,	NULL
Schroder	NULL
C	NULL
,	NULL
Kemier	NULL
R	NULL
,	NULL
Jackle	NULL
H	NULL
:	NULL
A	NULL
conserved	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
containing	NULL
structural	NULL
elements	NULL
of	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
Krupple	NULL
,	NULL
a	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
.	NULL

Cell	NULL
47:1025	NULL
,	NULL
1985	NULL
9	NULL
.	NULL

Hromas	NULL
R	NULL
,	NULL
Collins	NULL
S	NULL
,	NULL
Hickstein	NULL
D	NULL
,	NULL
Raskind	NULL
W	NULL
,	NULL
Deaven	NULL
L	NULL
,	NULL
O'Hara	NULL
P	NULL
,	NULL
Hagen	NULL
F	NULL
,	NULL
Kaushansky	NULL
K	NULL
:	NULL
A	NULL
retinoic	NULL
acid-responsive	NULL
human	NULL
zinc	NULL
finger	NULL
gene	NULL
,	NULL
MZF-1	NULL
,	NULL
preferentially	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:14183	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Bavisotto	NULL
L	NULL
,	NULL
Kaushansky	NULL
K	NULL
,	NULL
Lin	NULL
N	NULL
,	NULL
Hromas	NULL
R	NULL
:	NULL
Anti-sense	NULL
oligonucleotides	NULL
from	NULL
the	NULL
stage-specific	NULL
myeloid	NULL
zinc	NULL
finger	NULL
gene	NULL
MZEF-1	NULL
inhibit	NULL
granulopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
174	NULL
;	NULL
:1097	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Morris	NULL
J	NULL
,	NULL
Hromas	NULL
R	NULL
,	NULL
Rauscher	NULL
F	NULL
III	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
myeloid	NULL
zinc	NULL
finger	NULL
gene	NULL
MZF-1	NULL
:	NULL
Two	NULL
independent	NULL
DNA-binding	NULL
domains	NULL
recognize	NULL
two	NULL
DNA	NULL
consensus	NULL
sequences	NULL
with	NULL
a	NULL
common	NULL
G-rich	NULL
core	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1786	NULL
,	NULL
1994	NULL
12	NULL
.	NULL

Sadowski	NULL
I	NULL
,	NULL
Ptashne	NULL
M	NULL
:	NULL
A	NULL
vector	NULL
for	NULL
expressing	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
fusions	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:7539	NULL
,	NULL
1989	NULL
13	NULL
.	NULL

Lillie	NULL
JW	NULL
,	NULL
Green	NULL
MR	NULL
:	NULL
Transcriptional	NULL
activation	NULL
by	NULL
the	NULL
adenovirus	NULL
E1A	NULL
protein	NULL
.	NULL

Nature	NULL
346:76	NULL
,	NULL
1989	NULL
14	NULL
.	NULL

He	NULL
XY	NULL
,	NULL
Anato	NULL
VP	NULL
,	NULL
Basila	NULL
D	NULL
,	NULL
Marx	NULL
JC	NULL
,	NULL
Davis	NULL
BR	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD34	NULL
gene	NULL
.	NULL

Blood	NULL
79:2296	NULL
,	NULL
1992	NULL
15	NULL
.	NULL

He	NULL
XY	NULL
,	NULL
Cockerill	NULL
PN	NULL
,	NULL
Cen	NULL
D	NULL
,	NULL
Davis	NULL
BR	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
and	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
CD34	NULL
gene	NULL
promoter	NULL
region	NULL
.	NULL

Blood	NULL
83:1822	NULL
,	NULL
1994	NULL
16	NULL
.	NULL

Ho	NULL
SN	NULL
,	NULL
Hunt	NULL
HD	NULL
,	NULL
Horton	NULL
RM	NULL
,	NULL
Pullen	NULL
JK	NULL
,	NULL
Pease	NULL
LR	NULL
:	NULL
Site-directed	NULL
mutagenesis	NULL
by	NULL
overlap	NULL
extension	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Gene	NULL
77:51	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Wardhan	NULL
P	NULL
,	NULL
Gashler	NULL
A	NULL
,	NULL
Siegel	NULL
MG	NULL
,	NULL
Chang	NULL
LC	NULL
,	NULL
Joseph	NULL
LJ	NULL
,	NULL
Shows	NULL
TB	NULL
,	NULL
LeBeau	NULL
M	NULL
,	NULL
Sukhatme	NULL
VT	NULL
:	NULL
EGR-3	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
EGR	NULL
family	NULL
of	NULL
genes	NULL
encoding	NULL
immediate	NULL
early	NULL
transcription	NULL
factors	NULL
.	NULL

Oncogene	NULL
6:917	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Madden	NULL
SL	NULL
,	NULL
Cook	NULL
DM	NULL
,	NULL
Morris	NULL
JF	NULL
,	NULL
Gashier	NULL
VP	NULL
,	NULL
Sukhatme	NULL
VP	NULL
,	NULL
Rauscher	NULL
F	NULL
III	NULL
:	NULL
Transcriptional	NULL
repression	NULL
mediated	NULL
by	NULL
the	NULL
Wilm	NULL
's	NULL
tumor	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
253:1550	NULL
,	NULL
1991	NULL
19	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Moffat	NULL
LF	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
Recombinant	NULL
genomes	NULL
3647	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
2:1044	NULL
,	NULL
1982	NULL
20	NULL
.	NULL

Nordeen	NULL
SK	NULL
:	NULL
Luciferase	NULL
reporter	NULL
gene	NULL
vectors	NULL
for	NULL
analysis	NULL
of	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

Biotechniques	NULL
6:454	NULL
,	NULL
1988	NULL
21	NULL
.	NULL

Pahl	NULL
HL	NULL
,	NULL
Bum	NULL
TC	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Optimization	NULL
of	NULL
transient	NULL
transfection	NULL
into	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Exp	NULL
Hematol	NULL
19:1038	NULL
,	NULL
1991	NULL
22	NULL
.	NULL

Rosenthal	NULL
N	NULL
:	NULL
Identification	NULL
of	NULL
regulatory	NULL
elements	NULL
of	NULL
cloned	NULL
genes	NULL
with	NULL
functional	NULL
assays	NULL
.	NULL

Methods	NULL
Enzymol	NULL
152:704	NULL
,	NULL
1987	NULL
23	NULL
.	NULL

Sauer	NULL
F	NULL
,	NULL
Jackle	NULL
H	NULL
;	NULL
Concentration-dependent	NULL
transcriptional	NULL
activation	NULL
or	NULL
repression	NULL
by	NULL
Krupple	NULL
from	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
.	NULL

Nature	NULL
353:563	NULL
,	NULL
1992	NULL
24	NULL
.	NULL

Shi	NULL
Y	NULL
,	NULL
Seto	NULL
E	NULL
,	NULL
Chang	NULL
LS	NULL
,	NULL
Shenk	NULL
T	NULL
:	NULL
Transcriptional	NULL
repression	NULL
by	NULL
YY1	NULL
,	NULL
a	NULL
human	NULL
GLI-Krupple-related	NULL
protein	NULL
,	NULL
and	NULL
relief	NULL
of	NULL
repression	NULL
by	NULL
adenovirus	NULL
ElA	NULL
protein	NULL
.	NULL

Cell	NULL
67:377	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Wang	NULL
ZY	NULL
,	NULL
Qin	NULL
QQ	NULL
,	NULL
Deuel	NULL
T	NULL
:	NULL
The	NULL
Wilm	NULL
's	NULL
tumor	NULL
gene	NULL
product	NULL
WTl	NULL
activates	NULL
or	NULL
suppresses	NULL
transcription	NULL
through	NULL
separate	NULL
functional	NULL
domains	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:9172	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Reddy	NULL
JC	NULL
,	NULL
Morris	NULL
JC	NULL
,	NULL
Wang	NULL
J	NULL
,	NULL
English	NULL
MA	NULL
,	NULL
Haber	NULL
DA	NULL
,	NULL
Shi	NULL
Y	NULL
,	NULL
Licht	NULL
JD	NULL
:	NULL
WT-1-mediated	NULL
transcriptional	NULL
activation	NULL
is	NULL
inhibited	NULL
by	NULL
dominant	NULL
negative	NULL
mutant	NULL
proteins	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:10878	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Bum	NULL
TC	NULL
,	NULL
Satterthwaite	NULL
AB	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
The	NULL
human	NULL
CD34	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
antigen	NULL
promoter	NULL
and	NULL
a	NULL
3	NULL
'	NULL
enhancer	NULL
direct	NULL
hematopoietic	NULL
expression	NULL
in	NULL
tissue	NULL
culture	NULL
.	NULL

Blood	NULL
80:3051	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Melotti	NULL
P	NULL
,	NULL
Calabretta	NULL
B	NULL
:	NULL
Ets-2	NULL
and	NULL
c-myb	NULL
act	NULL
independently	NULL
in	NULL
regulating	NULL
expression	NULL
of	NULL
the	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
antigen	NULL
CD34	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:25303	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Morishita	NULL
K	NULL
,	NULL
Tsuchiya	NULL
M	NULL
,	NULL
Asano	NULL
S	NULL
,	NULL
Kaziro	NULL
Y	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Chromosomal	NULL
gene	NULL
structure	NULL
of	NULL
human	NULL
myeloperoxidase	NULL
and	NULL
regulation	NULL
of	NULL
its	NULL
expression	NULL
by	NULL
granulocyte	NULL
colony	NULL
stimulating	NULL
factor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
262:15208	NULL
,	NULL
1987	NULL
30	NULL
.	NULL

Johnston	NULL
J	NULL
,	NULL
Rintels	NULL
P	NULL
,	NULL
Chung	NULL
J	NULL
,	NULL
Sather	NULL
J	NULL
,	NULL
Benz	NULL
E	NULL
,	NULL
Berliner	NULL
N	NULL
:	NULL
Lactoferrin	NULL
gene	NULL
promoter	NULL
:	NULL
Structural	NULL
integrity	NULL
and	NULL
non-expression	NULL
in	NULL
HL60	NULL
cells	NULL
.	NULL

Blood	NULL
79:2998	NULL
,	NULL
1992	NULL
31	NULL
.	NULL

Hromas	NULL
R	NULL
,	NULL
Morris	NULL
J	NULL
,	NULL
Cornetta	NULL
K	NULL
,	NULL
Berebitsky	NULL
D	NULL
,	NULL
Davidson	NULL
A	NULL
,	NULL
Sha	NULL
M	NULL
,	NULL
Sledge	NULL
G	NULL
,	NULL
Rauscher	NULL
F	NULL
III	NULL
:	NULL
Aberrant	NULL
expression	NULL
of	NULL
the	NULL
myeloid	NULL
zinc	NULL
finger	NULL
gene	NULL
MZF-1	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
is	NULL
oncogenic	NULL
.	NULL

Cancer	NULL
Res	NULL
55:3610	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Vaziri	NULL
H	NULL
,	NULL
Dragowska	NULL
W	NULL
,	NULL
Allsop	NULL
RC	NULL
,	NULL
Thomas	NULL
TE	NULL
,	NULL
Hatley	NULL
CB	NULL
,	NULL
Lansdorp	NULL
PM	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
mitotic	NULL
clock	NULL
in	NULL
human	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
:	NULL
Loss	NULL
of	NULL
telomeric	NULL
DNA	NULL
with	NULL
age	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:9857	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
86	NULL
:	NULL
3640-3647	NULL
The	NULL
myeloid	NULL
zinc	NULL
finger	NULL
gene	NULL
,	NULL
MZF-1	NULL
,	NULL
regulates	NULL
the	NULL
CD34	NULL
promoter	NULL
in	NULL
vitro	NULL
4	NULL
,	NULL
8	NULL
5	NULL
p	NULL
'	NULL
ﬁ	NULL
'	NULL
f	NULL
)	NULL
..	NULL
os	NULL
2101	NULL
%	NULL
N	NULL
@	NULL
0	NULL
JF	NULL
Morris	NULL
,	NULL
FJ	NULL
3rd	NULL
Rauscher	NULL
,	NULL
B	NULL
Davis	NULL
,	NULL
M	NULL
Klemsz	NULL
,	NULL
D	NULL
Xu	NULL
,	NULL
D	NULL
Tenen	NULL
and	NULL
R	NULL
Hromas	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/10/3640.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

